Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
ProQR Therapeutics NV
F:0PQ
ProQR Therapeutics NV
F:0PQ
Price:
1.173
EUR
-1.35%
Market Closed
Market Cap:
€95.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
ProQR Therapeutics NV
F:0PQ
|
NL |
|
K
|
Komipharm International Co Ltd
KOSDAQ:041960
|
KR |
|
Celon Pharma SA
F:8RP
|
PL |
|
Prestige International Inc
OTC:PGINF
|
JP |
|
Centurion Acquisition Corp
NASDAQ:ALF
|
US |
|
G
|
Gentili Mosconi SpA
MIL:GM
|
IT |
|
V
|
Velocity Minerals Ltd
F:VMSP
|
CA |
Wall St Price Targets
0PQ Price Forecast
Based on 12 analysts
Based on 12 analysts
+514% Upside
from
€1.173
today
ProQR Therapeutics NV (0PQ)’s 12-month stock price forecast through October 2027 has a consensus target of €7.197, implying 514% upside. The forecast is based on price targets from 12 Wall Street analysts.
0PQ Analyst Rating
No ratings yet
No ratings yet
ProQR Therapeutics NV Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0PQ's stock price target?
Price Target
7.197
EUR
7.197
EUR
According to Wall Street analysts, the average 1-year price target for 0PQ is 7.197 EUR with a low forecast of 2.672 EUR and a high forecast of 13.891 EUR.
What is the Revenue forecast for ProQR Therapeutics NV?
Projected CAGR
50%
50%
Over the last 12 years, the compound annual growth rate for Revenue has been 51%. The projected CAGR for the next 8 years is 50%.